The order of the rows and columns do not need to be fixed but the column names must be exactly the same to the required (e.g. lowercase). The following columns are compursory: 'plate', 'compound', ...

Primary Wave Music has announced a “definitive” agreement to acquire Kobalt, one of the world’s largest independent music publishing and technology platforms, from Francisco Partners, creating a ...

A long-duration heat wave is taking shape over the western half of the U.S. and is forecast to stick around in the days ahead. A high-pressure system in place over the West is keeping precipitation ...

For decades, enthusiasts rode the cresting Eisbach creek in the southern German city, some 200 miles from the nearest coast. But the wave has vanished, prompting arguments about how to restore it. For ...

Investors bid up D-Wave Quantum immediately after earnings -- then sold as Wall Street lowered price targets. Investors in D-Wave must weigh weak current results against the possibility of a ...

Mapping peripheral to central pressure waveforms offers a promising approach for noninvasive assessment of the aortic pressure waveform. Traditional methods rely on population-based averaging, which ...

Enjoys fixing messy problems with clean code, good questions and the occasional AI assist. Enjoys fixing messy problems with clean code, good questions and the occasional AI assist. Enjoys fixing ...

On February 11, the pull request was technically sound. It offered 24% faster code with benchmarks to prove it. But when matplotlib maintainer Scott Shambaugh discovered the contributor was an AI ...

Sign of the times: An AI agent autonomously wrote and published a personalized attack article against an open-source software maintainer after he rejected its code contribution. It might be the first ...

D-Wave Quantum made a defining acquisition last month. The company now plans to lead in quantum annealing as well as gate-model systems. The valuation is high, and only risk-tolerant investors should ...

Wave Life Sciences has the fate of its lead RNA editing candidate back in its own hands. Partner GSK has decided not to take over development of WVE-006, an experimental oligonucleotide for alpha-1 ...